Introduction {#sec1}
============

Stem cells have a remarkable capacity to not only self-renew and differentiate but also to self-assemble and self-organize into complex and functional tissues and organs. An initially homogeneous population of stem cells can self-organize and undergo an *in vivo*-like morphogenesis to give rise to three-dimensional (3D) mini-organ-like structures in culture, called organoids ([@bib131]). They retain both functional and structural complexity of the tissue of origin and enable long-term growth of genetically stable cells. Organoids can be generated from embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) derived from patients that can be used for studying organ development, for modeling human diseases, and for autologous organ replacement. Tissue-specific adult stem cells (ASCs) can also generate organoids, and several protocols have been optimized for the same ([@bib20]). Here in this review, we limit our discussion to how pluripotent stem cells (PSCs, including ESCs and iPSCs) form 3D models of the embryo and organs in culture. This process involves recapitulation of implantation, gastrulation, and organogenesis, which altogether guide the key events during embryonic development when PSCs progressively commit to particular lineages. The cross talk between key signaling pathways during these developmental processes is the source of cellular diversity, behaviors, and forms that generate complex organ structure across the animal kingdom ([@bib112]). These signaling pathways form the basis for directed differentiation of PSCs to form "mini-organs" ([@bib131]) or embryo-like structures *in vitro* ([@bib136]). Although many reviews have addressed the principles of bioengineering to develop 3D cell culture models and protocols to generate organoids from adult tissues, here we present insights into the state-of-the-art knowledge on the self-organization property of PSCs to generate embryo-like structures and organoids, its advantage to model human diseases, and challenges for optimum clinical management.

An Overview of Self-Organization of Stem Cells to Form Embryo-like Structures {#sec2}
=============================================================================

Self-organization is a physical property observed in many biological phenomena ranging from collective behavioral traits to embryonic morphogenesis. ESCs derived from pre-implantation embryos are pluripotent and can clonally divide and differentiate into all cell types. ESCs can aggregate together into 3D embryoid bodies (EBs) with the presence of rudimentary cell types. Although EBs can differentiate into eye cups, neural cortical structures, and even cell types from endodermal and mesodermal lineages, they lack proper axial organization, a characteristic of mammalian embryo. Recent studies demonstrate the capability of ESCs to generate self-organizing embryo-like structures that can re-create early embryonic morphogenesis ([@bib136]; [@bib145]). The mammalian conceptus is composed of the placenta, the fetus, the extra-embryonic tissues to establish feto-maternal interaction, and the "embryo proper," which forms the main body ([@bib56]). The formation of extra-embryonic tissues and the generation of embryonic germ layers are the key stages of mammalian embryogenesis, which progress through a series of events from implantation of the conceptus to gastrulation followed by organogenesis ([Figure 1](#fig1){ref-type="fig"} A). The relatively small size of the conceptus and lack of protocols to culture along with ethical limitations to acquire human embryos inspired the generation of accessible stem cell-derived embryo models to understand the key stages of embryogenesis. Recent innovations have led to the generation of embryo-like structures that can recapitulate the interaction between embryonic and extra-embryonic tissues ([@bib49]; [@bib125]; [@bib138], [@bib139]; [@bib147]; [@bib194]). For example, human ESCs (hESCs) grown in microfluidic chambers can generate epiblast-like structures known as Post-implantation Amniotic Sac Embryoid (PASE), consisting of extra-embryonic tissues like the amniotic ectoderm, embryonic sac, and amniotic cavity, resembling early post-implantation human embryonic landmarks ([@bib138], [@bib139]; [@bib194]). Mouse stem cells can also self-organize into pre-implantation blastocyst-like structures called blastoids. Blastoids were formed by combining ESCs and extra-embryonic trophoblast stem cells (TSCs) ([@bib125]), ESCs/extended pluripotent stem cells (EPSCs) and TSCs ([@bib148]), or EPSCs alone ([@bib81]). Upon *in vitro* development, the ESCs ([@bib125]; [@bib148]) and the EPSCs ([@bib81]; [@bib148]) produced the primitive endoderm cells thus forming a pre-implantation conceptus comprising the three founding cell types. This was confirmed by independent single-cell RNA sequencing (scRNA-seq) analysis and also showed that blastoids formed with EPSCs only, and do not form cells with a proper trophoblast and epiblast transcriptome signature ([@bib116]). Additional work is needed to capture totipotent stem cells in a dish and form blastoids from only one cell type. Although blastoids are transcriptionally similar to blastocysts and can also trigger the formation of deciduae, they do not support *de novo* embryonic development beyond a few days (similar to all embryo models that are currently available) ([@bib81]; [@bib125]; [@bib148]). Similarly, self-organizing mouse ESCs (mESCs) in the presence of Wnt agonist and constant agitation can undergo spatial morphogenesis with distinct body axes, germ layer specification, and spatiotemporal gene expression, very much similar to a gastrulating embryo ([@bib10]; [@bib171]; [@bib179]). These "gastruloids" can be a complementary system to study early developmental events, and recent scRNA-seq. datasets provide evidence on the emergence of neural tube and somites recapitulating early organogenesis ([@bib170]; [@bib173]). Culturing mouse gastruloids with an underlying extracellular matrix led to the formation of structures resembling somites and neural tube ([@bib170]; [@bib173]), whereas another report suggested that mixing gastruloids and extra-endodermal cells can lead to the formation of the neural tube ([@bib11]). Recently, gastruloids have been generated from self-organizing hESCs, which can also differentiate to three germ layers ([@bib97]). Somite formation is a rhythmic process that involves molecular oscillation and the expression of certain genes that pattern the embryo, collectively known as the molecular segmentation clock that has been widely characterized in several model systems and PSCs ([@bib28]; [@bib86]; [@bib118]). The presence of an active segmentation clock in gastruloids similar to an *in vivo* embryo extends the power of this model system to characterize mammalian development ([@bib170]; [@bib173]). Nevertheless, the advent of blastoids and gastruloids from mESCs has opened new avenues to understand embryogenesis with wide application in biomedical discoveries especially for understanding developmental malformations. The advantage is its reproducible culture conditions that can be scaled up for any high-throughput studies and its key features strongly resembling an embryo (both in gene expression and axial organization) ([Figure 1](#fig1){ref-type="fig"}B, [Table 1](#tbl1){ref-type="table"} ). The generation of embryo-like structures and organoids is a recent breakthrough of stem cell self-organization with many fundamental questions still unanswered. This will open new avenues to understand germ layer specification in embryos with the possibility to generate organ structures inside embryo models.Figure 1Stem Cell-Derived Embryo Models Recapitulate Mammalian Embryonic Development(A) Illustration of the key stages of mammalian embryogenesis, showing the progression of embryonic development of the conceptus inside a reproductive tract *in vivo.*(B) Schematic of embryo-like structures generated from pluripotent stem cells *in vitro*, which can recapitulate the key events of the post-implantation process. These embryo-like structures include the blastoids (modeling the blastocyst stage), Post-implantation Amniotic Sac Embryoid (PASE) and ESC- and TSC-derived (ETS) embryo-like structures (modeling amniotic cavity formation and specification of mesoderm and endodermal layer), and gastruloids (modeling gastrulation and lineage specification with the formation of structures resembling somites and neural tube and early organogenesis). The bottom arrows represent a simplified version of the starting material that is mixed with PSCs to generate the embryo-like structures in a dish (see also [Table 1](#tbl1){ref-type="table"}).Table 1A Summary of Different Stem Cell-Based Embryo Models to Study Early Embryonic DevelopmentTypePSC SourceKey Features/Cell TypesReferencesPASEHuman ESC1.Resembles early post-implantation human embryonic development.2.Luminogenesis of the epiblast, pro-amniotic activity, formation of embryonic sac, and primordial germ cell specification.[@bib138], [@bib139]; [@bib194]BlastoidMouse ESCs and TSC, or mouse extended pluripotent stem cells alone1.Morphologically and transcriptionally resemble E3.5 blastocysts.2.Self-organization of mouse stem cells to form blastocyst-like structure containing epiblast (Epi), trophoectoderm (TE), and primitive endoderm (PE).3.Triggers decidualization upon *in utero* transfer and forms tissues that progress along developmental trajectories but with limited organization overtime (similar to all embryo models that are currently available). Live fetus or mice were not generated.[@bib81]; [@bib125]; [@bib148]ETX modelMouse ESC + TSC + XEN1.Consist of ESC-derived epiblast, TSC-derived extra-embryonic ectoderm, and XEN-derived visceral endoderm.2.Specifies mesoderm and definitive endoderm-like cells.3.Resembles E7 mid-gastrula-stage embryo[@bib147]GastruloidMouse ESC1.Trunk-like structures with mediolateral axis and left-right asymmetry, presence of somites with correct rostrocaudal patterning.2.Mimic embryonic spatial and temporal gene expression.3.Generate neural tube, mesodermal and endodermal derivatives, and presence of segmentation clock.[@bib10]; [@bib170]; [@bib173]Human ESC1.Form derivatives of three germ layers and undergo elongation along an anteroposterior axis.2.Signature of somitogenesis resembling Carnegie-stage-9 embryos. Lack anterior neural structures.[@bib97][^1]

A collective understanding of how ESCs can be manipulated *in vitro* to mimic developmental stages of the embryo ([@bib135]) is influential to generate more complex organ type *in vitro*. For example, the presence of an extracellular matrix, similar to a developing embryo, led to the formation of somites in gastruloids ([@bib170]; [@bib173]). The role of the laminin-rich extracellular matrix (also called Matrigel) in the growth and proliferation of intestinal tubules and mammary glands ([@bib79]; [@bib96]) led the foundation to initiate self-organizing structures from ESCs. Seminal discoveries include the generation of bilayered optic cup-like structures from self-organizing mESCs and hESCs ([@bib33]; [@bib70]) that can also differentiate *in vivo* into other retinal cell types after engraftment ([@bib143]). This triggered the concept that ESCs can be potentially utilized for organogenesis ([@bib101]; [@bib131]).

Mimicking Development to Generate Multi-lineage Organoids {#sec3}
=========================================================

Organoid generation utilizes the spatial and temporal gradients of morphogens that normally orchestrate embryonic development. One of the crucial aspects is the time and precise control of lineage promoting growth factors and expression of tissue-specific transcription factors (TFs). Organoids from tissue-specific ASCs rely on the activation of growth factors necessary for the maintenance of tissue type, whereas the sequential activation of signaling pathways in PSCs lead to the desired organoid type. The precise control of these early developmental processes is still poorly understood and imposes a major challenge for directed differentiation. Here, we present an overview of the concerted efforts of key signaling factors that promote PSC differentiation to self-organize into an organoid of a particular lineage ([Figure 2](#fig2){ref-type="fig"} A) and unique features associated with each organoid ([Table 2](#tbl1){ref-type="table"} ).Figure 2Directed Differentiation of PSCs to Generate Organoids of Three Different Germ Layers with the Strategies for Functional Validation and Its Biomedical ApplicationsA simplified roadmap for directed differentiation of PSC using growth factors from different signaling pathways (Wnt, BMP, TGF-β, Notch) to generate 3D cell culture models.(A) Signaling factors can also promote PSCs to a defined lineage bifurcating from ectoderm and PS. Complex organoid structures (assembloids) can be generated with vascularization or nervous system or coupling multi-endodermal structures. Faded color in the arrow denotes the ability to generate organoids from tissue-specific adult stem cells but not yet from PSCs (see also [Table 2](#tbl2){ref-type="table"} for features of organoids).(B) An overview of different available tools for functional characterization of 3D culture models.(C) The potential applications of organoids in biomedical research.Table 2Summary of the Organoids Generated from Pluripotent Stem Cells (PSCs) to Study Organ DevelopmentTypePSC SourceKey Features/Cell TypesReferences**Ectodermal Organoids**Cerebral organoidHuman ESC1.Formation of cerebral cortical neurons, choroid plexus, hippocampus, radial glial cells.2.Model human microcephaly.[@bib74]Forebrain spheroids (brain assembloid)Human ESC1.Model dorsal and ventral forebrain.2.Contain cortical glutamatergic or GABAergic neurons.[@bib13]Choroid plexus organoidHuman ESC1.Formation of blood-brain barrier2.Cerebrospinal fluid production.[@bib111]Pituitary organoidMouse ESC1.Pituitary progenitors committed to form endocrine tissues.2.Transplantation can rescue hypopituitary in mice[@bib153]Retinal organoid (optic cup)Mouse ESC,\
Human ESC1.Formation of optic vesicle.2.Generation of rod and cone cells.[@bib33]; [@bib178]Skin organoidMouse ESC1.Epidermal and dermal layers with *de novo* hair follicle development.2.Presence of specialized cutaneous cell types including melanocytes, sebaceous glands, hair shaft, and dermal papilla.[@bib76]Human ESC1.Epidermal and dermal layers with *de novo* hair follicle development.2.Network of sensory neurons and Schwann cells that interacts with Merkel cells associated with human touch.3.Able to form hair follicle after grafting under skin.[@bib78]Inner ear organoidMouse ESC1.Presence of mechanosensitive hair cells and specialized neurons.[@bib65]Human ESC1.Contains vestibular-like hair cells.2.Show similar electrophysiological properties as native hair cells.[@bib66]**Mesodermal Organoids**Cardiac organoidHuman ESC1.Cardiomyocyte proliferation.2.Resembles fetal heart.3.Modeling regenerative response following cryoinjury.[@bib50]; [@bib177]Kidney organoidHuman ESC\
Human iPSCs1.Differentiate into ureteric epithelium resembling embryonic kidney.2.Can vascularize into glomerulus-like structures with interconnecting renal tubules and collecting ducts.[@bib98]; [@bib158]**Endodermal Organoids**Lung organoidHuman ESC1.Formation of alveolar and airway-like structures, presence of basal and secretory cells.2.Used for cystic fibrosis modeling[@bib32]; [@bib57]; [@bib88]Esophageal organoidHuman ESC1.Consists of proliferative basal progenitors and differentiated stratified squamous epithelium.[@bib167]; [@bib193]Liver organoidHuman iPSCs1.Interaction between endothelial cells and mesenchymal cells.2.Functional vascular network.[@bib159]Hepatic-biliary-pancreatic organoidHuman ESC/iPSC1.Invaginating liver, bile duct, and pancreatic-like tissue.2.Formation of bile ducts and hepatic epithelium following transplantation in mice[@bib67]; [@bib184]Gastric organoidMouse ESC\
Human ESC1.Differentiate into antral and fundus cell types, mucus-producing cells2.Modeling *Helicobacter pylori* infection[@bib89], [@bib90]Pancreatic organoidHuman ESC1.Differentiate into ductal and acinar cells similar to human fetal pancreas.[@bib51]Intestinal organoidHuman ESC1.Characteristic villus and crypt-like structures.2.Recapitulates duodenum and ileum.3.Assembled with functional enteric nervous system[@bib149]; [@bib168]; [@bib180]; [@bib183]

Ectodermal Organoids {#sec3.1}
--------------------

During gastrulation, the primitive streak (PS) forms at the midline, where epiblast cells undergo epithelial-to-mesenchymal transition and ingress to form the mesoderm and endoderm. The cells that do not ingress form the ectodermal layer, which patterns to form epidermal cells and most of the central nervous system. Neuro-epithelium is induced in self-organizing PSCs cultured in serum-free media, which evaginates to form neural retina, but a timed notch signaling generates the photoreceptors ([@bib33]; [@bib178]). Inhibiting transforming growth factor (TGF)-β and bone morphogenetic protein (BMP) signaling (blocks mesendodermal commitment) leads to definitive ectoderm formation and neuroectoderm commitment. Furthermore, an additional Wnt activation leads to the formation of cranial neural crest, and a pulse of BMP4 with a block of FGF signaling leads to the formation of non-neural ectodermal fate ([@bib165]). Following neuroectodermal fate, PSCs can self-organize into EBs that can be guided to form distinct areas of the brain or can even recapitulate the whole brain containing discrete brain regions with cortical neurons ([@bib74]). This has been extended to generate cerebral organoids from human PSCs to recapitulate different brain regions including the hippocampus, midbrain, hypothalamus, cerebellum, and choroid plexus (reviewed in [@bib73]; [@bib29]; [@bib119]). Choroid plexus organoids derived from PSCs can secrete cerebrospinal fluid and have the ability to form blood-brain-barrier ([@bib111]). The interaction of the hypothalamic neuroectoderm along with non-neural ectoderm also led the path to generate anterior pituitary organoid expressing multiple endocrine lineages ([@bib153]). Non-neural ectoderm also gives rise to inner-ear and the skin appendages. A combination of BMP activation and TGF-β inhibitor can differentiate PSCs into non-neural ectoderm with the formation of more specialized pre-placoidal cells and a distinct population of mechanosensitive hair cells ([@bib65], [@bib66]). Skin organoids also utilize a similar differentiation strategy, where individual hair follicles grow with prominent hair shaft, adipocytes, melanocytes, and sebaceous glands ([@bib76]). scRNA-seq analysis of hESC-derived skin organoids also validated the presence of 16 cell clusters that resemble human skin, keratinocytes. Interestingly, grafting these organoids under the skin can generate hair follicles ([@bib78]), a breakthrough in regenerative medicine that can be used to treat skin diseases and rejuvenating burnt skin or scar tissues. Hair follicle development shares a close analogy to the development of other skin appendages like the dental, and the mammary gland ([@bib93]). Although 3D *in vitro* culture method for culturing teeth ([@bib103]) and mammary glands ([@bib59]) have been developed, generating them from PSCs is still not successful. A deeper investigation of the aforementioned growth factors can be used to generate organoids from teeth, salivary glands, and the mammary gland. Understanding the differentiation hierarchy of mammary, salivary, and dental stem cells ([@bib61]; [@bib102]; [@bib175]) will be important to generate PSC-derived mammary organoids. Although a mosaic mammary gland is generated by reprogramming dental epithelial stem cells mixed with mammary epithelial cells (MECs) ([@bib60]) or by mixing mESCs with MECs ([@bib14]), generating organoids is not reported. Human iPSCs can be directed to generate mammary organoids; however, they failed to reconstitute *in vivo* ([@bib120]), suggesting that a fine-tuning of growth factors and timing is critical to recapitulate the mammary microenvironment in organoids.

Intermediate Primitive Streak Specification for Mesodermal and Endodermal Organoids {#sec3.2}
-----------------------------------------------------------------------------------

Organoids of mesodermal and endodermal lineage require an intermediate PS induction in PSCs. PS formation is a major event during gastrulation; anterior PS gives rise to definitive endoderm and paraxial mesoderm (source of bone, cartilage, and fibroblasts), whereas the mid-PS generates the cardiac and limb bud progenitors. Dual SMAD signaling (BMP4 and TGF-β) activation leads to PS formation in ESCs while blocking ectodermal commitment. BMP4 in the presence of FGF2 is the critical regulator that leads to the upregulation of mesoderm-related genes (*Brachyury, Cdx2, Tbx3, and Gata4*) in hESCs ([@bib46]), whereas TGF-β inhibition accelerates mesoderm formation from PS and blocks endoderm specification ([@bib83]). This strategy was used to differentiate ESCs into hematopoietic precursor ([@bib110]; [@bib191]) and endothelial progenitors ([@bib40]) that was instrumental in the formation of cardiac organoids resembling human fetal hearts ([@bib177]). However, differentiated cardiomyocytes do not recapitulate the structural complexity of a mammalian heart ([@bib26]; [@bib99]) despite showing cardiac electrophysiological response ([@bib94]). This is partly due to the complex architecture of the heart requiring multilineage interactions and paracrine signaling from adjacent tissues. A recent study utilized co-emerging cardiac-like mesoderm and gut-like endoderm from iPSCs that can attain adult heart-type complexity with non-contractile myocytes and blood vessels surrounding it ([@bib144]). Human PSCs can intrinsically self-organize to form cardiac mesoderm without exogenous extracellular matrix proteins and consist of separate myocardial and endothelial layers. The cardiac organoids (cardioids) can also form cavities resembling the heart chambers, which overall opens new avenues to understand cardiogenesis during embryonic development ([@bib50]). Insights from 2D culture suggests that cardioids can be further enhanced to form regionalized cell types by inhibiting Retinoic Acid (RA) and Wnt signaling to generate ventricular cells, or activating them to generate atrial-like cells ([@bib27]; [@bib192]). Organoids resembling blood vessel can also be generated that can integrate with the host vasculature ([@bib181]), which brings hope to develop organoids of particular lineage coupled with endothelial cells or fused with blood vessel organoids to recapitulate complex organ structure, as recently evidenced in vascularized cortical organoids ([@bib15]; [@bib142]). Human PSCs can be differentiated into ureteric epithelium or metanephric and mesonephric mesenchyme *in vitro* that recapitulates embryonic kidney ([@bib155]; [@bib156]; [@bib157], [@bib158]), or even generate kidney organoids from epiblast spheroids ([@bib37]; [@bib98]). One of the major feats of kidney-like organoids from PSCs is its incredible ability to vascularize into glomerulus-like structures with interconnecting renal tubules and collecting ducts ([@bib9]; [@bib172]; [@bib141]; [@bib169]). A reproducible and a scalable 3D organoid culture strategy is developed that supports vascularization in an animal model and therefore brings great promise to regenerative medicine ([@bib67]; [@bib160]).

Endodermal Organoids {#sec3.3}
--------------------

Activating TGF-β signaling at the PS stage leads to the definitive endodermal lineage that gives rise to the internal lining of the lungs, and intestinal tracts and other vital organs like thyroid, thymus, liver, and pancreas. During embryonic development, the endoderm layer gives rise to a primitive gut tube broadly divided into fore, mid, and hindgut, from where other vital organs bud off. This is achieved by using a nodal-related TGF-β signaling molecule, activin-A, which promotes the differentiation of PSCs to the definitive endoderm expressing SOX17 and FOXA2 ([@bib23]). Dual inhibition of BMP and TGF-β signaling generates anterior foregut endoderm (AFE), which self-assembles to generate organoids of the esophagus, lung, parathyroid, and thymus. The SOX2+ p63+ progenitors that are responsible for esophageal organoids block the Wnt-BMP signaling required for ventral foregut to generate NKX2-1+ lung progenitors ([@bib167]; [@bib193]). However, lung progenitors can also be induced by the addition of FGF10, FGF7, and a low concentration of BMP4 ([@bib54]; [@bib182]) or simultaneous stimulation of WNT and FGF along with high Hedgehog signaling ([@bib32]). Notably, the NKX2-1 progenitors give rise to basal, secretory cells leading to the formation of the airway and alveolar cells, characteristic of the human lung ([@bib54]; [@bib57]; [@bib88]), but they mostly resemble a fetal lung, thereby raising the concern of organoid maturity *in vitro*. NKX2-1+ cells are considered to be a bipotent progenitor population, and Wnt-BMP-FGF signaling differentiates them from being lung versus thyroid ([@bib25]; [@bib69]; [@bib134]). The thyroid progenitors can also form organoids and can maintain TH level after xenotransplantation in the mouse model ([@bib69]). Thymic organoids are still not successful, but thymic progenitors can be generated by activating BMP4, RA, Wnt3A, and FGF8b, and inhibiting hedgehog signaling can differentiate into T cells *in vitro* but failed to support prolonged thymogenesis *in vivo* ([@bib109]; [@bib154]).

The posterior foregut endoderm specifies the formation of the liver, stomach, and pancreas. FGF and BMP4 are pre-hepatic cues that induce the formation of liver progenitors from activin-induced endoderm ([@bib43]). Simultaneous inhibition of hedgehog signaling while activating RA results in pancreatic fate ([@bib24]). Another strategy utilized the mixing of endothelial and mesenchymal cells that can instruct human iPSC-derived hepatic endoderm to self-organize into liver bud organoids ([@bib159], [@bib161]). The liver buds can further differentiate into bile duct cells (activating Notch and TGF-β) or to hepatocytes (blocking Notch and TGF-β) ([@bib4]). A complex architecture can be established by mixing biliary and hepatic cells to generate hepato-biliary organoids that can form bile ducts and hepatic epithelium after transplantation in mice ([@bib184]). Moreover, fusing anterior and posterior gut spheroids from iPSC-derived definitive endoderm can also assemble into multi-endodermal domains to form hepato-biliary-pancreatic organoids ([@bib67]). The generation of the complex organoid system holds tremendous potential as models for studying organogenesis.

While considerable progress has been made in generating multi-organ structures, compartmentalization of organ structures is also evident. For example, gastric organoids can be regionalized into the antral part ([@bib44]; [@bib89]), which upon Wnt and FGF10 activation leads to fundus ([@bib90]), pancreatic organoids can generate beta cells (β) using keratinocyte growth factor and also resemble the ductal and acinar morphology of human fetal pancreas ([@bib51]). The pancreatic progenitors can form insulin-producing β cells and can maintain glucose levels after transplantation in diabetic mice ([@bib108]). Multiple *in vitro* differentiation protocols have resulted in pancreatic progenitors, but the critical goal to derive functional β cells is of high biomedical value. However, insulin production is taken as a gold standard to mark β cells; these functional β cells often co-express other hormones leading to the co-occurrence of contaminating lineages ([@bib137]). Although unprecedented progress has been made toward generating β cells *in vitro*, the existence of unwanted lineages imposes significant concerns that need to be addressed for successful therapeutic application. scRNA-seq on PSC-derived pancreatic organoids compared with the human pancreas will be instrumental to identify the correct lineage to its closest approximation.

A similar level of compartmentalization is evident in intestinal organoids with characteristic villus and crypt-like structures ([@bib149]; [@bib180]), which upon short exposure to FGF4 and Wnt activation recapitulates duodenum and longer exposure generates ileum ([@bib168]). The colon organoids are generated from the hindgut endoderm in the presence of BMP signaling ([@bib21]; [@bib100]), and, embryologically the caudal extension leads to the prostate, bladder, and penile urethra. Not much is known regarding prostate, urethral, and bladder organoid generation from PSCs. Although directed differentiation of hESCs using Wnt10B and FGF expresses prostate-specific transcription factor NKX3.1 and androgen-regulator TMPRSS2 ([@bib17]), this study focused entirely on NKX3.1 expression as a definitive factor for prostate organoid. Several studies on knockout mice have revealed the function of Hoxb1 and Sox9 in prostate commitment irrespective of NKX3.1 status, and detailed characterization of ESC-derived prostate organoids is required with characteristic molecular markers ([@bib166]).

Overall, the focus has been on generating organoids from a single lineage *in vitro* that provides insights to organ development, but it fails to recapitulate multi-tissue interactions necessary for organ function. The development of multi-lineage organoids opens new avenues to obtain personalized micro-physiological models for modeling developmental organogenesis *in vitro*. Few examples include the fusion of neural spheroids or cortical organoids ([@bib8]; [@bib13]; [@bib186], [@bib187]), generating hybrid neuromuscular organoids ([@bib34]), fusing anterior and foregut endoderm for hepato-biliary and pancreatic organoid structures ([@bib67]), and generating intestinal organoids with a functional enteric nervous system ([@bib183]). Multi-lineage organoids generated from co-emerging cardiac and gut lineage specification from iPSCs can be useful to model heart complexity better than conventional cardiac organoids. These organoids consist of mature cardiomyocytes, stromal epicardial cells, and blood-vessel-like structures along with the primitive gut that resembles the intestine ([@bib144]). The emergence of multilineage organ models will be useful to map paracrine interaction and also understand the role of adjacent organ tissues required for organ maturation. Collectively, these studies present a common set of signaling factors (Wnt, BMP, TGF-β, Hedgehog, Notch) that work in a coordinated and chronological manner to decide the cell fate ([@bib68]). A thorough identification of the appropriate cocktail of growth factors is crucial to generate correct cell types, and validation using a variety of tools ranging from microscopy to scRNA-seq is necessary ([Figure 2](#fig2){ref-type="fig"}B).

Stem Cell-Based Embryo Models and Organoids for Clinical Management {#sec4}
===================================================================

Embryo-like structures and organoids derived from PSCs have diverse scientific applications ranging from modeling mammalian development to understanding disease outcomes ([@bib20]; [@bib72]; [@bib129]; [@bib140]). Although *in vitro* and *in vivo* models including 2D coculture, microfluidics, tissue engineering, humanized animals, and chimeras are used for decades to model human diseases and drug screening, they have their advantages and associated challenges. Here we present a comprehensive overview of the current applications of PSC-derived 3D culture systems, along with strategies to overcome the challenges to make it accessible for regenerative medicine and cell-based therapeutics ([Figure 2](#fig2){ref-type="fig"}C).

Understanding Embryogenesis and Organ Development {#sec4.1}
-------------------------------------------------

iPSCs can be differentiated to form gastruloids and blastoids that can help to understand rare human diseases. "Rare diseases" collectively affect a significant population, which has led to developmental malformations in infants. Despite efforts that have been made to understand the genetic underpinnings of rare diseases, we still have limited clinical progress and lack therapeutic strategies ([@bib3]; [@bib163]). Given the robustness of iPSC generation from a variety of genetic disorders including Parkinson disease, Down syndrome, and Huntington disease, understanding the defects in early embryogenesis will be helpful from iPSC-derived embryo like structures. Although there is a limitation in the number of patients, the patient-iPSC-derived organoids/gastruloids will be particularly useful to model a genetic disorder, perform drug screening, and understand embryonic development. Mutations in genes associated with the segmentation clock lead to defects in vertebrae. Several other clinically relevant mutations exist that can be useful to study in gastruloids to model developmental anomalies and also perform functional screening. The optimized culture conditions allow *in vitro* cultures of embryos beyond implantation and provide a broader understanding of pregnancy loss and improve contraception technologies. A major advantage of using stem cell-based embryo models is to utilize them for studying human embryonic development as they represent an ethical alternative to replace the use of embryos. These models should only be used to better understand embryonic development and the origin and treatment of diseases in a dish ([@bib56]; [@bib124]).

Disease Modeling and Functional Screening of Genetic Variants {#sec4.2}
-------------------------------------------------------------

Organoids have been widely used to model both congenital and acquired diseases including several age-related disorders and infectious diseases ([@bib72]). Brain organoids from patient-derived iPSCs are utilized to model neurodegenerative disorders and also to recapitulates human brain development ([@bib29]). To name a few, different types of brain organoids have been used to model microcephaly, Alzheimer disease, and neuro-progenitor abnormality after Zika virus infection (reviewed in [@bib2]). Similarly, gastric organoids are used to model *Helicobacter pylori* infection ([@bib89]). A recent study utilized a wide spectrum of organoids generated from human PSCs to understand the viral transmission in different human organs. However, the lack of immune system in organoids may be a limiting factor in these studies to accurately understand the viral immune response ([@bib189]). The generation of thymus epithelial progenitors from PSCs opens another avenue to the ever-growing organoid community. Thymus is one of the specialized organs that plays a major role during infection and other age-related disorders. Thymic organoids capable of T cell differentiation will be particularly applicable for treating several autoimmune diseases ([@bib109]; [@bib154]). On the other hand, a major population globally experiences hearing disorder, and inner ear organoids bring hope to utilize them for personalized medicine. Although transplanting retinal organoids to macular degeneration in primates were successful, the development of ESC-derived inner ear organoids is still in its infancy and needs some fine-tuning before being utilized for regenerative therapies. Furthermore, these organoids can be used for high-throughput drug screening to identify novel targets that promote survival/regeneration of sensory hair cells or show ototoxicity. It also holds great promise to gain insights into genetic mutations affecting inner ear development ([@bib126]; [@bib164]) and model hearing loss defects. Skin organoids are able to regenerate hair follicles under the skin and can be used as bioengineered skin grafts in regenerative surgery [@bib78]. Organoids can be a powerful tool to functionally characterize genetic variants and pancreatic organoids are recently used to study diabetes-causing gene variants ([@bib87]), and similar strategies should be implemented to understand other disease-causing mutations.

Around 4.6 million missense variants are reported for disease-causing mutations in the Genome Aggregation Database (GnomAD), of which 99% are rare, and only 2% have a clinical interpretation in ClinVar ([@bib19]; [@bib150]). Much of our understanding of clinical management comes from ClinVar, but the majority are still considered to be "variants of uncertain significance" ([@bib75]; [@bib122]) ([Figure 3](#fig3){ref-type="fig"} A). Most of the disease-causing mutations reported in ClinVar are point mutations, and currently, a broad understanding of single-nucleotide variants (SNVs) comes from generating transgenic mice, which is often very laborious and time consuming. To this end, several *in vitro* functional assays have been developed to screen disease-causing missense variants, but it often fails to recapitulate the disease outcome ([@bib95]). Although high-throughput screenings (HTSs) have accelerated the identification of pathogenic and neutral variants of several disease-causing genes ([@bib35]; [@bib48]), they fail to comment on its tumorigenic potential in patients. It is not trivial to generate transgenic model organisms to understand the function of individual variants and its disease-causing potential. An alternative approach could be the use of base editors and prime editors ([@bib6]) to generate SNVs in ESCs, which can be differentiated to organoids of interest (as described previously) ([Figure 3](#fig3){ref-type="fig"}B). This will leverage its potential for *in vivo* functional studies and reduce the generation of genetically engineered mouse models.Figure 3Applications of PSC-Derived Organoids in Personalized Medicine and Clinical Management(A) The disease-causing variants are cataloged in several public clinical databases and are used for functional studies.(B) Different variants can be generated in PSCs using the CRISPR-based genome editing toolbox, which can be further differentiated to the organoid of the desired lineage. The organoids represent each patient/variant, and high-throughput drug screening and cytotoxicity studies can be performed to develop a personalized drug.(C) Schematic showing the use of organoids in high-throughput genetic screens using CRISPR to identify novel gene targets that get frequently mutated to cause cancer. Furthermore, these organoids can be xenotransplanted to develop an *in vivo* model for mouse tumorigenesis studies. The resulting tumors can be further cryopreserved as organoids for drug screening and mutagenesis studies.

Drug Screening, Biobanks and the Hope of Using Personalized Medicine {#sec4.3}
--------------------------------------------------------------------

Multiple HTS platforms have been developed using iPSCs, which have advanced our understanding of drug development and toxicity studies ([@bib45]). It has just started to be applied in organoids for drug screening ([@bib22]). These screening platforms are very cost effective and reduce any manual error thereby generating uniform organoids more successfully in clinical drug development. During the past decade, tissue engineering and bioprinting technologies have revolutionized our understanding of simulating 3D organ complexity. This allows multiple cell types to be integrated and grown together in 3D culture systems that are compartmentalized by membranes or microchannels to mimic the *in vivo* environment ([@bib12]). Developing an "organ-on-a-chip" concept to generate vascularized multi-lineage organoid along with HTS platforms will play a critical role to improve the scalability and uniformity of organoid generation. As it simulates to its maximum capability, these novel technological insights surely improve our understanding of organ development *in vitro,* but not all microfluidics can recapitulate the organ complexity. Breakthroughs have been made to integrate multi-organs in a chip ([@bib185]) and coupling these with multilineage organoids will be of high biomedical relevance. Generating organoid biobanks are crucial for personalized medicine, as it brings the ability to perform high-throughput drug screening, epigenomic and transcriptomic analysis, and copy number variations of individual patients at a large scale. While biobanks have been generated for breast cancer, gastric cancer, pediatric kidney cancer, and glioblastoma ([@bib16]; [@bib58]; [@bib130]; [@bib188]), these can be extended to the development of organoid biobanks with individual disease variants generated in ESCs, or from iPSCs of rare diseases. We hope to see patient-variant organoid biobank in the future that will accelerate personalized drug development.

High-throughput CRISPR-Based Genetic Screens {#sec4.4}
--------------------------------------------

Recent advances in genome editing, especially with the advent of CRISPR-Cas9 (clustered regularly interspaced sort palindromic repeats-CRISPR-associated protein 9), have revolutionized our understanding of human disease and have been a powerful tool to correct genetic mutations in human organoids ([@bib39]; [@bib133]). Although genome editing is a routine technique in 2D cell lines, it requires optimizations to improve its efficiency. Characterizing correctly edited organoids is a major challenge, and some strategies rely on the removal of culture media constituents, antibiotic selection, or fluorescence-activated cell sorting (FACS) after transfection ([@bib7]; [@bib30]; [@bib38]; [@bib132]). For example, removal of Wnt and R-spondin from culture medium selects survival of APC^KO^ intestinal organoids, and further addition of Nutlin3 allows selection of APC and P53 double^KO^ organoids ([@bib31]).

CRISPR and other nucleases have been classically used to understand the function of individual genes by making knockouts or tracking particular cell types using reporter organoids ([@bib7]; [@bib85]). Although this "one-gene-at-a-time" approach was crucial to establish the power of genome editing in organoids, it fails to validate a large number of genomic threats underlying a disease. Genome sequencing studies have identified several infrequent mutations that hit together with commonly mutated genes. Some driver mutations that are often considered to be rare can form aggressive cancers and are the guiding force behind genetic heterogeneity in tumors ([@bib105]; [@bib176]). To better understand these rare events, genome-wide CRISPR screens are a powerful tool to get an overview of less frequent but actionable genes ([Figure 3](#fig3){ref-type="fig"}C). Pooled CRISPR screens are increasingly popular to model these synergistic interactions and identify tumor suppressors and other novel cancer driver genes. The generation of Cas9 knock-in mice was instrumental to extend the *in vivo* genome editing toolbox that accelerated high-throughput CRISPR screens in organoids ([@bib114]). This led to the initial reports on CRISPR loss-of-function screens in biliary epithelial cell organoids to identify genes necessary for liver regeneration ([@bib113]) and also for identifying co-occurring mutations in colorectal cancer ([@bib162]). These studies looked into a specific pool of genes as whole-genome-wide screens in organoids were not successful due to several technical limitations.

Although growth factor selection assay is a powerful method to identify mutated organoids ([@bib31]; [@bib85]), similar niche factor dependence strategies need to be devised for studying other gene perturbations. Moreover, the heterogeneous growth of organoids from transduced single organoid cell suspension introduces variability in guide RNA (gRNA) representation and downstream sequencing analysis. To overcome these shortcomings, the development of barcoded sequencing of individual organoids compared with bulk sequencing has proved to be a good alternative to perform genome-wide knockout screens ([@bib123]). Furthermore, pooled screens coupled with xenotransplantation of organoids *in vivo* can be used to perform tumorigenesis studies ([Figure 3](#fig3){ref-type="fig"}C). While large-scale mouse mutagenesis screens are a valuable tool for functional genomics, it require large research infrastructure and can be time consuming and laborious ([@bib41]). Transplantation of human colonic organoids transduced with a pool of gRNAs led to the identification of recurringly mutated tumor suppressor genes and some novel mediators that were not previously associated with colorectal cancer ([@bib92]). Organoid xenografts in mouse models to study cancer metastasis can be a powerful alternative to mouse mutagenesis screens ([@bib106]; [@bib127]).

Most forward genetic screen studies are performed on ASC-derived organoids, whereas there are no studies reported on CRISPR screens on PSC-derived organoids. Generating missense variants in ESCs or patient iPSC-derived organoids can be utilized in the future to study synergistic gene interactions and also for selective drug response. Several synthetic-lethal relationships have been reported that forms the basis of drug development to treat several cancers; however, multiple studies have also reported on its low efficacy or selective survival ([@bib53]; [@bib104]). For example, PARP and ATR inhibitors that have revolutionized cancer treatment have shortcomings and CRISPR activation and knockout screens have identified the genetic basis behind resistance and ways to improve sensitivity. However, 2D cell lines fail to recapitulate the interaction of stem cells and the associated microenvironment, which plays a major role in drug sensitivity. Future studies on genome-wide CRISPR screens will be very useful to understand a particular drug response in patient-derived organoids for personalized medicine ([Figure 3](#fig3){ref-type="fig"}C). Apart from disease modeling, forward genetic screens in organoids can be utilized for optimizing niche growth factors and stem cell differentiation strategies and identifying conditions for organoid maturation ([@bib80]).

Challenges and Future Perspectives {#sec5}
==================================

Despite paramount success in generating organoids from ESCs and iPSCs, the technologies are still in their infancy for use in the clinic. Genome instability and loss of heterozygosity during extensive rounds of *in vitro* culture and the introduction of *de novo* mutations during somatic reprogramming impose serious concerns on utilizing iPSCs. Moreover, the epigenetic memory and DNA methylation status of the parent somatic cells from where iPSCs are generated also affect cell fate ([@bib42]; [@bib55]; [@bib82]). Collectively these limitations in iPSCs are potential threats to utilize them for robust organoid generation, especially for therapeutics. Recent advances to correct disease-causing mutations using different CRISPR-based genome editing tools in iPSCs followed by organoid generation is a promising avenue for regenerative medicine; however, they need to be tested for CRISPR off-target events that may have other harmful consequences. *In vitro* differentiation of PSCs into organoids often resembles the embryonic stage and lacks proper maturation, another hurdle to utilize them for functional studies. These organoids can differentiate into mature cell types after orthotopic transplantation, suggesting that cues from the *in vivo* microenvironment enhance maturity and tissue functionality. Recent advances in organoid protocols have addressed this issue using bioengineering platforms to obtain adult-like tissues ([@bib52]). The generation of interconnected vasculature has just begun using a mesenchyme-driven self-condensation method. Organ buds are reported from multiple tissue types including the liver, intestine, lung, kidney, heart, and brain ([@bib160]). The lack of vasculature generates a hypoxic environment leading to increased necrosis or apoptotic cells in organoids. Endothelial cells can be mixed with lineage progenitors to generate vascularization in organoids. Injectable organoids have recently been developed in hydrogels that can also generate perfusive vasculature in mice *in vivo* ([@bib128]). Although improved vasculature is currently used, engineering organoids with other surrounding tissue types are necessary. To this end, assembloids have emerged to model the structural interactions between subdomains of an organ that opens the opportunity to couple multi-lineage differentiation. Organ systems are mostly associated by surrounding muscles, nerves, and immune cells that are critical for organ function; engineering organoids containing a neuronal network along with blood vasculature is something to foresee in the future.

Another major challenge is the considerable amount of ambiguity that exists in identifying the correct lineage progenitors, which leads to cell heterogeneity and inter-organoid variability. Spontaneous differentiation due to long-term culture can generate unwanted lineages ([@bib164]) and the high frequency of contaminating progenitors compared with the desired cell types during *in vitro* differentiation of PSCs can affect organoid reproducibility ([@bib174]; [@bib190]). Therefore "separating the wheat from the chaff" is important to generate organoids, as a minor population of undifferentiated human PSCs has a higher chance to give rise to teratoma (tumor) that often out-competes organ reconstitution *in vivo* ([@bib36]). Heterogeneity of both differentiated and undifferentiated PSCs is a common problem, and therefore using specific cell surface markers can efficiently generate the desired lineage. FACS is a powerful method to sort the correct cell type based on surface markers but can often affect the cell population thereby reduces its efficiency ([@bib63]). A current gold standard to draw an analogy in organ recapitulation is to perform bulk transcriptomic sequencing or correlating protein expression in PSC-derived organoids with respective desired tissue. However, this often outnumbers the exact cell type and fails to detect the presence of a minor population of contaminating lineage. The development of scRNA-seq is instrumental to get a comprehensive view of cell-type composition in an organoid. Although limitations to scRNA-seq exist with overarching challenges of not being able to detect lowly expressed gene clusters ([@bib64]), the high-omics dataset can assess any inter-organoid variability and gives high confidence to utilize them to model a particular organ type. A large-scale transcriptomic profiling study at the single-cell level in brain organoid has identified six distinct clusters to neuroectodermal type and one cluster of cells of mesodermal origin ([@bib121]). A stepwise affirmation with scRNA-seq at different phases of differentiation could better mimic organ development *in vitro*. This led to the generation of a nearly pure cell population of PS that can differentiate to other mesodermal cell types ([@bib84]). Therefore, understanding cell types and state in a particular organoid using diverse technologies ranging from transcriptomics profiling to lineage tracing at single-cell level ([@bib91]) will be crucial to establish PSC-derived organoids as robust and consistent models for functional studies ([Figure 2](#fig2){ref-type="fig"}C).

Not all stem cell lines have similar potency to generate organoids of a particular lineage as observed in the ability to generate retina, inner ear, and skin organoids from ESCs ([@bib76]; [@bib107]; [@bib178]). Analysis of 162 differentiation strategies from 61 PSC lines identified Wnt/β catenin signaling leads to the varied differentiation ability, and its activation could alleviate the outcomes ([@bib151]). Future strategies should focus on empirically investigating the organoid-forming efficiency for each ESC line before initiating functional studies. Some common factors that decide the efficiency are self-assembling property of PSCs, effects of Matrigel concentration, precise timings of morphogens, and variable epigenetic status. Matrigel being a biological material may have batch effects, therefore alternative synthetic scaffolds has just begun to be explored ([@bib1]). Moreover, the cytotoxicity of the chemical inhibitors may also affect cell cycle/growth, giving inconsistencies in cellular differentiation ([@bib71]). Thus, overexpressing tissue-specific TFs can be an alternative to induce differentiation in PSCs as evident in generating hepatocyte-like cells *in vitro* ([@bib47]), thyroid follicular organoids ([@bib5]), thymus progenitors ([@bib152]), and intestinal organoids from PSCs ([@bib146]). A collaborative effort to fine-tune the timing and concentration of biochemical and biophysical cues will increase the success and reproducibility. The advent of genome editing to rectify a faulty gene with personalized organoids is what we foresee for precision medicine in a personalized era. Although the "bench-to-bedside" transition of organoids may take some time, early pre-clinical studies are very promising with the increasing trend for commercializing organoids for disease modeling and regenerative medicine ([@bib18]).

Conclusion {#sec6}
==========

Research on stem cell-based embryo models (blastoids and gastruloids) and organoids will be increasingly popular in the coming years with more opportunities to utilize them for regenerative medicine. These 3D models have already been proved to be an exciting platform for personalized therapies, the above challenges need to be overcome, and efforts have to be made to increase the yield and reproducibility. Future research will look into expanding these platforms to other animal model systems. Some examples include the generation of brain organoids from other non-human primates to study the evolution of the nervous system and brain maturation ([@bib62]; [@bib115]), generation of snake venom gland organoids for anti-venom production ([@bib117]), and generation of bat intestinal organoids for modeling viral infection ([@bib195]). Most of our fundamental understanding of signal transduction pathways that we exploit to generate "mini-organs in a dish" comes from studying animal development. Generating self-organizing structures from stem cells in other animal models will provide deep molecular evolutionary insights and a detailed appreciation of developmental networks. The conservation of gene regulatory networks will help to understand the evolution of the structure and function of organs.
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[^1]: PASE, Post-implantation Amniotic Sac Embryoid ; XEN, extra endodermal cell; TSC, Trophoblast stem cells.
